Vivus unveils obesity management capsule in US
Qsymia requires to be taken as an adjunct to a reduced-calorie diet and increased physical activity for obesity management by patients with improper body mass index along with
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of Cushing’s syndrome of endogenous origin.